Skip to main content

Table 3 Chemotherapy details

From: Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis

Characteristics

CRT group

Referent group

NAC (%) N=15

CC (%) N1=45, N2=56

AC (%) N=12

NAC (%) N=15

CC (%) N1=51, N2=50

AC (%) N=12

Cycles

      

3-weekly regimen

      

1

8 (53.3)

5 (11.1)

7 (58.3)

6 (40.0)

5 (9.8)

7 (58.3)

2

7 (46.7)

26 (57.8)

5 (41.7)

9 (60.0)

30 (58.8)

5 (41.7)

3

0 (0.0)

14 (31.1)

0 (0.0)

0 (0.0)

16 (31.4)

0 (0.0)

Weekly regimen

      

5

0 (0)

23 (41.1)

0 (0)

0 (0)

20 (40.0)

0 (0)

6

0 (0)

22 (39.3)

0 (0)

0 (0)

19 (38.0)

0 (0)

7

0 (0)

11 (19.6)

0 (0)

0 (0)

11 (22.0)

0 (0)

Dose modification

3 (20.0)

21 (20.8)

4 (33.3)

2 (13.3)

4 (4.0)

2 (16.7)

  1. Abbreviations: NAC, Neo-adjuvant chemotherapy; CC, Concurrent chemoerapy; AC, Adjuvant chemotherapy.